arrow
L

Lina Liu

Department of Breast Oncology
H指数:24
被引数:2,614

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial

新型CDK2/4/6抑制剂culmerciclib (TQB3616) 联合氟维司群治疗HR阳性HER2-negative晚期乳腺癌: 一项随机、双盲、3期临床试验

2025-12-180
OAAI
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells
2024-08-020
PRE
Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 Trial
2024-05-020
PRE